Skip to main
MNPR
MNPR logo

Monopar Therapeutics (MNPR) Market Capitalization Overview

Market Cap: $204.99M as of Jun 13, 2025

$204.99M
Past Month-$36.88M (15.25%)
As of Jun 13, 2025, Monopar Therapeutics (MNPR) has a market capitalization of $204.99M. Over the past 30 days, its market cap has decreased by -30.42%, while in the last 12 months, it has increased by 53.34%.

Market capitalization represents the total value of Monopar Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Monopar Therapeutics (MNPR) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Monopar Therapeutics (MNPR) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Monopar Therapeutics (MNPR) Market Cap History

DateMarket CapChange
Jun 2, 2025$183.52M-30.42%
May 1, 2025$263.76M+29.29%
Apr 1, 2025$204.01M+8.08%
Mar 3, 2025$188.76M-28.98%
Feb 3, 2025$265.77M+96.84%
Jan 2, 2025$135.02M+16.23%

Monopar Therapeutics (MNPR) End of Year Market Cap History

DateMarket CapChange
2025$204.99M+53.34%
2024$133.69M+2,667.57%
2023$4.84M-84.15%
2022$30.47M-24.66%
2021$40.44M-42.31%
2020$70.10M

FAQs About Monopar Therapeutics (MNPR) Market Cap

As of Jun 13, 2025, the market capitalization of Monopar Therapeutics (MNPR) is $204.99M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Monopar Therapeutics’s market capitalization has decreased by -15.25%, changing from $241.86M to $204.99M as of Jun 13, 2025.

In the last 3 months, Monopar Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Monopar Therapeutics’s market capitalization increased from $4.84M in January to $133.69M in December, reflecting a 2,667.57% change.

In the past five years, Monopar Therapeutics (MNPR) has had a compound annual growth rate (CAGR) of 13.78% in market capitalization. This means its market cap has grown at an average rate of 13.78% per year.

Monopar Therapeutics (MNPR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.